Isik EG - Search Results

1

Somatostatin receptor-positive breast lesions on ⁶⁸Ga-DOTATATE PET/CT.

Has Simsek D, Isik EG, Engin MN, Kuyumcu S, Mudun A, Sanli Y. Has Simsek D, et al. Among authors: isik eg. Ann Nucl Med. 2021 Feb;35(2):270-277. doi: 10.1007/s12149-020-01570-8. Epub 2021 Jan 5. Ann Nucl Med. 2021. PMID: 33400149

2

Impact of Nonosseous Findings on (18)F-NaF PET/CT in a Patient with Ductal Breast Carcinoma.

Kuyumcu S, Adalet I, Isik EG, Unal SN. Kuyumcu S, et al. Among authors: isik eg. Nucl Med Mol Imaging. 2014 Mar;48(1):72-4. doi: 10.1007/s13139-013-0235-3. Epub 2013 Sep 19. Nucl Med Mol Imaging. 2014. PMID: 24900141 Free PMC article.

3

An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography.

Has Şimşek D, Kuyumcu S, Bilgiç B, Işık EG, Türkmen C, Adalet I. Has Şimşek D, et al. Among authors: isik eg. Mol Imaging Radionucl Ther. 2016 Oct 5;25(3):147-149. doi: 10.4274/mirt.93064. Mol Imaging Radionucl Ther. 2016. PMID: 27751979 Free PMC article.

4

Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of ¹⁸FDG-PET/CT according to ΔSUV_max, Deauville 5-point scale and IHP criteria.

Isik EG, Kuyumcu S, Kebudi R, Sanli Y, Karakas Z, Cakir FB, Unal SN. Isik EG, et al. Ann Nucl Med. 2017 Nov;31(9):660-668. doi: 10.1007/s12149-017-1196-x. Epub 2017 Jul 24. Ann Nucl Med. 2017. PMID: 28741053

5

Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?

Simsek DH, Sanli Y, Civan C, Engin MN, Isik EG, Ozkan ZG, Kuyumcu S. Simsek DH, et al. Among authors: isik eg. Ann Nucl Med. 2020 Jul;34(7):476-485. doi: 10.1007/s12149-020-01474-7. Epub 2020 May 11. Ann Nucl Med. 2020. PMID: 32394269

6

Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.

Civan C, Isik EG, Simsek DH. Civan C, et al. Among authors: isik eg. Clin Nucl Med. 2021 Apr 1;46(4):e212-e213. doi: 10.1097/RLU.0000000000003362. Clin Nucl Med. 2021. PMID: 33156050

7

Squamous Cell Carcinoma Mimicking Neck Paraganglioma on 68Ga-DOTATATE PET/CT.

Civan C, Isik EG, Has Simsek D, Sen C, Unal SN. Civan C, et al. Among authors: isik eg. Clin Nucl Med. 2021 Jul 1;46(7):e368-e370. doi: 10.1097/RLU.0000000000003555. Clin Nucl Med. 2021. PMID: 33630807

8

Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

Has Simsek D, Kuyumcu S, Karadogan S, Oflas M, Isik EG, Ozkan ZG, Paksoy N, Ekmekcioglu O, Ekenel M, Sanli Y. Has Simsek D, et al. Among authors: isik eg. Ann Nucl Med. 2021 Jun;35(6):680-690. doi: 10.1007/s12149-021-01610-x. Epub 2021 Mar 30. Ann Nucl Med. 2021. PMID: 33783752

9

Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04.

Kuyumcu S, Kovan B, Sanli Y, Buyukkaya F, Has Simsek D, Özkan ZG, Isik EG, Ekenel M, Turkmen C. Kuyumcu S, et al. Among authors: isik eg. Clin Nucl Med. 2021 Aug 1;46(8):641-646. doi: 10.1097/RLU.0000000000003667. Clin Nucl Med. 2021. PMID: 33883494

10

An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (¹⁷⁷Lu)-DOTATATE.

Kovan B, Özkan ZG, Demir B, Tunçman D, Işik EG, Şimşek DH, Büyükkaya F, Türkmen C, Şanli Y. Kovan B, et al. Among authors: isik eg. Cancer Biother Radiopharm. 2022 Feb;37(1):17-22. doi: 10.1089/cbr.2021.0071. Epub 2021 Jun 16. Cancer Biother Radiopharm. 2022. PMID: 34134512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters